文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

去甲肾上腺素与去氧肾上腺素对急性腹部急诊手术患者肾素-血管紧张素-醛固酮系统及术后并发症的影响:一项随机对照试验

Phenylephrine Vs. Norepinephrine on the Renin-Angiotensin-Aldosterone System and Postoperative Complications in Acute Abdomen Emergency Surgery: A Randomized Controlled Trial.
PubMed 文献 · Crit Care Med · 2025-10-21
一句话结论急性腹部急诊手术中,去氧肾上腺素与去甲肾上腺素对肾素-血管紧张素-醛固酮系统组分及术后并发症的影响相似;术前血浆肾素水平较高与升压药需求更大及术后并发症发生率更高相关。

该单中心随机对照试验纳入156例18岁以上在全身麻醉下接受急性腹部急诊手术的患者,随机分为去氧肾上腺素组或去甲肾上腺素组,术中维持平均动脉压70-80 mm Hg。去甲肾上腺素组术后即刻血浆肾素水平升高(中位差值21 μIU/mL,四分位距5-51,p=0.020),而去氧肾上腺素组未升高(中位差值7 μIU/mL,四分位距-1至33,p=0.336);两组术后24小时血浆肾素水平均显著下降,血管紧张素II和醛固酮水平也降低。术前血浆肾素水平上四分位数与更高的升压药需求和更高的急性肾损伤发生率相关。两组急性肾损伤发生率(相对危险度1.50,95%置信区间0.65-3.47,p=0.569)、心肌损伤(相对危险度1.11,95%置信区间0.64-1.93,p=0.497)及30天死亡率(相对危险度1.00,95%置信区间0.44-2.27,p=1.000)无显著差异。作者认为去氧肾上腺素与去甲肾上腺素对肾素-血管紧张素-醛固酮系统组分及术后并发症的影响相似。

要点

  • 急性腹部急诊手术全身麻醉患者术中维持平均动脉压70-80 mm Hg时,去氧肾上腺素组与去甲肾上腺素组术后急性肾损伤发生率无显著差异(相对危险度1.50,95%置信区间0.65-3.47,p=0.569)。
  • 去甲肾上腺素组术后即刻血浆肾素水平较术前升高(中位差值21 μIU/mL,四分位距5-51,p=0.020),而去氧肾上腺素组未升高(中位差值7 μIU/mL,四分位距-1至33,p=0.336)。
  • 两组术后24小时血浆肾素水平均显著下降,血管紧张素II和醛固酮水平也降低。
  • 术前血浆肾素水平上四分位数与更高的升压药需求和更高的急性肾损伤发生率相关。
  • 两组心肌损伤(相对危险度1.11,95%置信区间0.64-1.93,p=0.497)及30天死亡率(相对危险度1.00,95%置信区间0.44-2.27,p=1.000)无显著差异。

适用人群与场景

  • 18岁以上在全身麻醉下接受急性腹部急诊手术的患者,共156例,来自徐州医科大学附属医院麻醉科。

处置流程与药物剂量

  • 术中分别使用去氧肾上腺素(去氧肾上腺素组)或去甲肾上腺素(去甲肾上腺素组)维持平均动脉压70-80 mm Hg。

研究设计与关键结果

  • 研究类型为随机对照试验,纳入156例18岁以上在全身麻醉下接受急性腹部急诊手术的患者,随机分为去氧肾上腺素组和去甲肾上腺素组。
  • 去甲肾上腺素组术后即刻血浆肾素水平升高(中位差值21 μIU/mL,四分位距5-51,p=0.020),去氧肾上腺素组未升高(中位差值7 μIU/mL,四分位距-1至33,p=0.336)。
  • 两组术后24小时血浆肾素水平均显著下降,血管紧张素II和醛固酮水平也降低。
  • 术前血浆肾素水平上四分位数与更高的升压药需求和更高的急性肾损伤发生率相关。
  • 两组急性肾损伤发生率(相对危险度1.50,95%置信区间0.65-3.47,p=0.569)、心肌损伤(相对危险度1.11,95%置信区间0.64-1.93,p=0.497)及30天死亡率(相对危险度1.00,95%置信区间0.44-2.27,p=1.000)无显著差异。

证据类型、等级与局限

  • 随机对照试验;作者结论认为去氧肾上腺素与去甲肾上腺素对肾素-血管紧张素-醛固酮系统组分及术后并发症的影响相似。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 在急性腹部急诊手术全身麻醉患者中,术中使用去氧肾上腺素或去甲肾上腺素维持平均动脉压70-80 mm Hg对术后急性肾损伤、心肌损伤及30天死亡率的影响无显著差异。
  • 术前血浆肾素水平上四分位数与更高的升压药需求和更高的急性肾损伤发生率相关,作者认为术前血浆肾素水平较高与升压药需求更大及术后并发症发生率更高相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to explore how phenylephrine (PE) and norepinephrine (NE) affect renin-angiotensin-aldosterone system (RAAS) components and postoperative complications in patients undergoing acute abdomen emergency surgery.

DESIGN: A randomized controlled trial.

SETTING: The Anesthesiology Department at the Affiliated Hospital of Xuzhou Medical University.

PATIENTS: We enrolled 156 patients 18 years older who were undergoing emergency acute abdominal surgery under general anesthesia.

INTERVENTIONS: Patients were randomized to receive PE (PE group) or NE (NE group) to maintain their mean arterial pressure at 70-80 mm Hg during operation.

MEASUREMENTS AND MAIN RESULTS: The plasma renin level increased in the immediate postoperative period in the NE group (median difference [MD]: 21 μIU/mL (interquartile range [IQR]: 5-51], p = 0.020), but not in the PE group (MD: 7 μIU/mL [IQR: -1 to 33], p = 0.336). However, the plasma renin levels were significantly decreased in both groups at 24 hours postoperation. Furthermore, in both groups, the levels of angiotensin II and aldosterone were reduced at 24 hours postoperation. The upper quartile of the plasma renin level before surgery was associated with higher vasopressor requirements and higher acute kidney injury (AKI) incidence. Furthermore, the groups showed no significant difference in AKI incidence (relative risk [RR]: 1.50 [95% CI, 0.65-3.47], p = 0.569), myocardial injury (RR: 1.11 [95% CI, 0.64-1.93], p = 0.497), and 30-day mortality rate (RR: 1.00 [95% CI, 0.44-2.27], p = 1.000).

CONCLUSIONS: PE and NE exert similar effects on RAAS components and postoperative complications. A higher plasma renin level before surgery is associated with greater vasopressor requirement and a higher incidence of postoperative complications.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Chen J, Wang X, Yin T, et al. Phenylephrine Vs. Norepinephrine on the Renin-Angiotensin-Aldosterone System and Postoperative Complications in Acute Abdomen Emergency Surgery: A Randomized Controlled Trial. Crit Care Med. 2025. PMID: 41123386. doi:10.1097/CCM.0000000000006912

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。